David Simmons

Operating Partner*

David Simmons joined H&F in an advisory role as an Operating Partner in 2022 and serves as a member of H&F’s CEO Council, an advisory group for H&F portfolio company CEOs. David brings over 25 years of deep industry expertise and leadership experience and helps drive value creation initiatives across H&F portfolio companies, with particular focus on the healthcare sector. 

David was previously Chairman and Chief Executive Officer of PPD, Inc., an H&F portfolio company, from 2012 to 2021, when PPD was acquired by Thermo Fisher Scientific. At PPD, he led the company’s global workforce of approximately 26,000 employees across 46 countries, in the design and execution of drug development programs on behalf of pharmaceutical industry customers. Prior to PPD, David spent 15 years at Pfizer, Inc., where he served as President of Emerging Markets and Established Products business units. David currently serves on the Boards of Directors of Cordis and Medline, both H&F portfolio companies, as well as CURIA, a biopharmaceutical manufacturing company and Launch Therapeutics, a medicine development company.


Carnegie-Mellon University

*Operating Partners and Senior Operating Advisors serve as advisors to, and are not employees of, Hellman & Friedman.